Aerospace and Defense
Company Overview of Russian Technologies State Corporation
Russian Technologies State Corporation, through its subsidiaries, engages in the development, manufacture, and exportation of high technology industrial products for civil, military, and dual-purpose markets in the Russian Federation and internationally. It designs and manufactures electronic warfare means, IFF systems, radio measuring instrumentation, and demountable connectors and the goods of civil purpose; combat automatic and sniper’s weapons, guided projectiles, and civil products; and optoelectronic systems, military and civil systems, optical materials, medical devices, and energy-saving lighting technologies. It provides aviation units, power supply systems, and parachute systems; p...
24, Usacheva str.
Founded in 2007
Key Executives for Russian Technologies State Corporation
Chief Executive Officer of Rosoboronexport
Chief Executive Officer of Oboronprom
Chief Executive Officer of Russian Helicopters
Deputy Director General and Member of Managing Board
Compensation as of Fiscal Year 2014.
Russian Technologies State Corporation Key Developments
Rostec Might Get 32.4% State Stake In Sintez
Oct 2 14
The Russian government plans to transfer a 32.4% stake in SINTEZ Group JSC to Russian Technologies State Corporation.
Rostec and Genfa Sign Memorandum for Investments of up to $100 Million to Create a Joint Venture to Produce Medicines
Sep 30 14
Rostec and Genfa have signed a memorandum for investments of up to $100 million to create a joint venture to produce medicines. The main purpose of the joint venture is to localize medicine production and ultimately reach full-cycle development, clinical trials, production and distribution. The location of the enterprise is set to be determined by the end of 2014, and the plant will be built in 2015-2016. It will focus on biotechnology, oncological medication and hormonal medicine. In addition, the joint venture will develop its own line of medicines to replace more than 30 imported drugs, and also produce generics of existing medicines in more complex and key segments of the market: oncology, neurology, nephrology, hematology and others. Around 60 drugs are planned to be produced at the factory, all of which will replace their imported counterparts. The plant will produce up to 1 million units per year in its first phase. Under the agreement, the two parties intend to work together on the development of a state and private partnership in the field of producing medicinal preparations, including vaccines and products derived from blood. Also planned are comprehensive projects with foreign companies aimed at the transfer of leading technologies and localizing the production of up-to-date immunobiological products in Russia. In addition, Rostec will play a role in the development of proposals for the updating of the country's standards and legal regulation system for the turnover of medical goods.
Rostech To Reportedly Sell 75% In Izhevsk Mechanical Plant To Businessman
Sep 26 14
Russian Technologies State Corporation is reportedly planning to sell 74.9% stake of Izhevsk Mechanical Plant to Andrei Bokarev. The deal, which is to be approved on a corporate level, will go through two additional emissions; first, 51% of shares will be issued in January-March 2015, and the rest of securities later. The deal's value will be determined after an independent evaluation of the plant. In any case, the plant is non-core asset of Rostech, but requires investment, the state-owned corporation said.
Similar Private Companies By Industry
Recent Private Companies Transactions